ArticleFrontiers in oncology2022

A systematic pan-cancer analysis of PXDN as a potential target for clinical diagnosis and treatment.

Xiaohu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.